Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA gassy, bloated stomach is one of the most commonly reported side effects of Wegovy (semaglutide). It happens because the medicine slows how quickly food leaves your stomach, and that delay can let gas build up in your gut. For most people it settles within a few weeks, particularly after a dose increase, but understanding what's driving it helps you decide whether to ride it out, adjust your habits, or check in with your prescriber. These are prescription-only medicines, so any changes to your treatment should go through a clinician who knows your history.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works by mimicking GLP-1, a hormone your gut releases after eating. One of its effects is slowing how quickly food moves from your stomach into the small intestine, a process called gastric emptying. That slowdown is part of what makes you feel full for longer. It's also, bluntly, why you can feel like a slowly inflating balloon after meals.
When food lingers in the stomach, fermentation by gut bacteria produces more gas than usual. Swallowed air has less opportunity to pass through quickly. The result is bloating, belching, flatulence, and that uncomfortable pressure that sometimes sits right under your ribs. The semaglutide medicine page has a fuller rundown of how GLP-1 agonists act in the body, which puts this in context.
The reason this matters for your decision is straightforward: the gassiness isn't a malfunction. It's a predictable consequence of the same action that makes the medicine effective. That doesn't mean you have to accept it without question, but it does mean the first question to ask is whether it's settling over time, not whether something has gone wrong.
A quick check you can do in under a minute: think back to what you ate in the four hours before your symptoms were worst. Large portions, high-fat meals or fizzy drinks will reliably intensify gas on Wegovy in ways that relate to how the medicine acts in your stomach in a way they might not have before. Spotting that pattern gives you something actionable to change before assuming the medicine is the whole story.
Gas and bloating on Wegovy tend to follow a predictable curve. They're often sharpest in the first few days after starting or increasing a dose, then ease off as the weeks pass. This mirrors the wider stomach discomfort pattern that most people notice across the titration schedule.
The standard Wegovy schedule moves through several doses over many months before reaching the maintenance level, and each step can briefly restart the settling-in process. Some people sail through every increase; others find certain dose steps harder than others. There's no reliable way to predict in advance which you'll be.
What tends to make it worse at any dose: eating large meals rather than smaller, more frequent ones; high-fat foods, which slow emptying further; carbonated drinks; and eating quickly. What tends to help: smaller portions, taking your time at the table, staying well hydrated with still water, and keeping protein intake reasonable so you're not compensating for reduced appetite with foods that are harder to digest.
There is also a timing element worth knowing. Gas and bloating are listed side effects in the NHS patient information for semaglutide, described as common. That classification reflects the trial data: gastrointestinal side effects were reported by a substantial proportion of participants, though most were mild to moderate and transient. Knowing they're expected and documented is genuinely reassuring for most people who contact us about this.
Most gassiness on Wegovy doesn't need anything beyond patience and a few dietary adjustments. The cases worth a prescriber conversation look different: stomach symptoms that are severe, getting worse rather than improving after two or three weeks at the same dose, or accompanied by pain that spreads toward your back, persistent vomiting, or signs of dehydration. Those warrant prompt medical attention rather than a self-management plan.
The MHRA has highlighted acute pancreatitis as an uncommon but serious condition associated with GLP-1 medicines, the key symptom is severe, persistent stomach pain that may reach through to the back. It's rare, but it's the reason you shouldn't dismiss stomach pain that feels different from ordinary gas.
If your gas is uncomfortable but not severe, and it follows the typical post-dose pattern, dietary changes are a reasonable first step. There's a broader look at how Wegovy works and what to expect across treatment that covers similar ground. If adjustments aren't helping or you're uncertain whether what you're feeling is typical, that's exactly the kind of question a prescriber should answer rather than a search engine.
For anyone considering whether Wegovy is right for them from the start, questions about tolerability are part of what gets discussed at consultation, including your medical history and anything that might affect how your system handles GI side effects. You can read more about weight-loss treatment options to understand how Wegovy fits alongside other licensed approaches.
Beyond waiting for adjustment, a few concrete changes make a consistent difference for people dealing with gas on Wegovy. Portion size is the single biggest lever. The medicine reduces appetite, but eating to the old serving size anyway overwhelms a stomach that's already emptying slowly. Smaller meals, more often, suits the physiology.
Cutting back on carbonated drinks is low effort and tends to help quickly. Reducing high-fat foods (especially in the first weeks at a new dose) is also consistently useful. Not because fat is the enemy, but because it's the macronutrient that most slows gastric transit even without a GLP-1 medicine involved.
Chewing thoroughly and eating without rushing lets you respond to satiety cues rather than ploughing through a meal before they register. It sounds obvious, but it's harder than it seems when eating habits are long-established. Our frequently asked questions cover a range of similar practical queries from people on treatment.
If you're managing your treatment through persistent gassiness on Wegovy and finding it difficult to tolerate, that's worth raising before your next dose increase is due. Prescribers can slow titration, discuss dose timing relative to meals, or assess whether something else might be contributing, and our page on why semaglutide makes some people particularly gassy explains the underlying reasons in more detail. The right call depends entirely on your individual picture, which is why speaking to our prescribers directly is the most useful step if self-management isn't enough.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.